methylprednisolone has been researched along with montelukast in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (52.63) | 29.6817 |
2010's | 9 (47.37) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gøransson, LG; Omdal, R | 1 |
Abe, M; Hayashi, Y; Katsuragi, T; Murai, A; Sakata, N; Tanaka, K | 1 |
Hrycek, A; Kajor, M; Pochopień-Kenig, G; Wanat-Wiśniewska, M | 1 |
Fedor, ME; Rubinstein, A | 1 |
Chipps, B | 1 |
Berger, PB; Blankenship, JC; Hubbard, CR; Scott, TD; Skelding, KA | 1 |
Aynali, G; Başpinar, S; Gümüş, S; Karahan, N; Tüz, M; Yariktaş, M; Yasan, H | 1 |
Colombo, G; Della-Torre, E; Della-Torre, F; Pignatti, P; Sabbadini, MG; Tresoldi, M; Yacoub, MR | 1 |
Jiang, Z; Liu, X; Lyu, L | 1 |
Altas, M; Aras, M; Cavus, G; Ozgür, T; Sefil, F; Serarslan, Y; Ulutas, KT; Yilmaz, N | 1 |
Calvo, C; de la Serna, O; Fernandez-Prieto, A; Lopez-Gutierrez, JC; Marin-Aguilera, B; Méndez-Echevarría, A; Parron, M | 1 |
Engelhardt, M; Munder, M; Salwender, H; Scheid, C | 1 |
Ding, X; Ji, W; Liang, Y; Wu, H; Zhao, D | 1 |
1 review(s) available for methylprednisolone and montelukast
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for methylprednisolone and montelukast
Article | Year |
---|---|
Effect of montelukast combined with methylprednisolone for the treatment of mycoplasma pneumonia.
Topics: Acetates; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclopropanes; Cytokines; Drug Therapy, Combination; Female; Humans; Leukotriene Antagonists; Male; Methylprednisolone; Pneumonia, Mycoplasma; Prognosis; Quinolines; Sulfides; T-Lymphocyte Subsets | 2019 |
17 other study(ies) available for methylprednisolone and montelukast
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A severe systemic inflammatory reaction following therapy with montelukast (Singulair).
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Cyclopropanes; Dose-Response Relationship, Drug; Female; Glomerulonephritis; Humans; Hypereosinophilic Syndrome; Methylprednisolone; Middle Aged; Prednisolone; Quinolines; Sulfides | 2000 |
Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Topics: Acetates; Airway Resistance; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bile; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Hypersensitivity; In Vitro Techniques; Leukocyte Count; Leukotriene A4; Leukotriene Antagonists; Leukotrienes; Lung; Methylprednisolone; Quinolines; Rats; Rats, Inbred BN; Receptors, Leukotriene; Sulfides | 2005 |
[Churg-Strauss syndrome--a case report].
Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antihypertensive Agents; Churg-Strauss Syndrome; Combined Modality Therapy; Cyclopropanes; Female; Humans; Hypertension; Methylprednisolone; Middle Aged; Quinolines; Sulfides | 2006 |
Effects of long-term low-dose corticosteroid therapy on humoral immunity.
Topics: Acetates; Agammaglobulinemia; Albuterol; Anti-Asthmatic Agents; Antibodies, Bacterial; Antibody Formation; Asthma; B-Lymphocytes; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Immunologic Memory; Lymphopenia; Methylprednisolone; Middle Aged; Nasal Polyps; Pneumococcal Vaccines; Quinolines; Sinusitis; Sulfides; T-Lymphocyte Subsets | 2006 |
Systemic reaction to omalizumab.
Topics: Acetates; Adrenal Cortex Hormones; Aged; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis; Asthma; Cyclopropanes; Depression; Drug Hypersensitivity; Drug Therapy, Combination; Epinephrine; Female; Humans; Hypersensitivity; Hypertension; Methylprednisolone; Omalizumab; Quinolines; Rhinitis; Salmeterol Xinafoate; Seizures; Sulfides; Syncope | 2006 |
Emergency pretreatment for contrast allergy before direct percutaneous coronary intervention for ST-elevation myocardial infarction.
Topics: Acetates; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Antiemetics; Cimetidine; Contrast Media; Cyclopropanes; Drug Hypersensitivity; Drug Therapy, Combination; Emergency Medical Services; Heart Conduction System; Histamine H2 Antagonists; Humans; Leukotriene Antagonists; Methylprednisolone; Myocardial Infarction; Prochlorperazine; Quinolines; Sulfides; Time Factors | 2008 |
The effects of methylprednisolone, montelukast and indomethacine in experimental otitis media with effusion.
Topics: Acetates; Administration, Oral; Animals; Biopsy, Needle; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Immunohistochemistry; Indomethacin; Injections, Intraperitoneal; Male; Methylprednisolone; Otitis Media with Effusion; Otoscopy; Quinolines; Random Allocation; Rats; Rats, Wistar; Reference Values; Statistics, Nonparametric; Sulfides; Treatment Outcome | 2011 |
Optimal management of DRESS syndrome in course of infectious endocarditis.
Topics: Acetates; Aged; Anti-Bacterial Agents; Cyclopropanes; Drug Eruptions; Endocarditis, Bacterial; Eosinophilia; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Quinolines; Sulfides; Syndrome; Treatment Outcome; Vancomycin | 2013 |
[A case of neuroendocrine cell hyperplasia of infancy (NEHI)].
Topics: Acetates; Cyclopropanes; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Hyperplasia; Infant; Lung; Lung Diseases, Interstitial; Methylprednisolone; Neuroendocrine Cells; Quinolines; Sulfides; Tomography, X-Ray Computed | 2014 |
Effects of montelukast and methylprednisolone on experimental spinal cord injury in rats.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Creatine Kinase; Cyclopropanes; Glutathione Peroxidase; L-Lactate Dehydrogenase; Laminectomy; Male; Malondialdehyde; Methylprednisolone; Neuroprotective Agents; Nitric Oxide; Quinolines; Rats, Wistar; Spinal Cord Injuries; Sulfides; Superoxide Dismutase | 2014 |
Acute Lung Toxicity After Intralesional Bleomycin Sclerotherapy.
Topics: Acetates; Acute Lung Injury; Bleomycin; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intralesional; Methylprednisolone; Quinolines; Risk Assessment; Sclerotherapy; Sulfides; Tomography, X-Ray Computed; Treatment Outcome; Vascular Malformations | 2018 |
[Infusion of Daratumumab in Combination Therapies - Practical Information for The Outpatient Area].
Topics: Acetates; Ambulatory Care; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclopropanes; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Methylprednisolone; Multiple Myeloma; Premedication; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Time Factors | 2018 |